This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical tri…

Stargardt DiseaseCone Rod DystrophyJuvenile Macular Degeneration+1 more

~Estimated

~$10 – $8,750

Ascidian Therapeutics, IncNCT06467344

Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligib…

Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more

~Estimated

~$10 – $1,050

Ascidian Therapeutics, IncNCT06445322

Adaptive Optics Imaging of Outer Retinal Diseases

The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina incl…

Retinal DegenerationAge-Related Macular DegenerationRetinitis Pigmentosa+7 more

~Estimated

~$10 – $1,125

Food and Drug Administration (FDA)NCT05355415